Therapeutic Expertise

Infectious Disease (Hepatitis and Vaccine)

Accelerating Clinical Development for Hepatitis Disease

  • Nearly 20 years’ project experience and a broad range of expertise in Hepatitis B and C
  • A comprehensive set of clinical and regulatory services covering Phase I-IV studies at a global level
  • We are able to leverage strong site relationships and patient access, to quickly assess feasibility and accelerate enrollment and move trials forward
  • Well-established risk-based monitoring plans to ensure high-quality data
  • Successfully delivered a number of clinical trials of Class 1 innovative hepatitis B drugs in China from 2018 to 2021

Indications on Hepatitis

Liver protection

Hepatitis C

Hepatitis B

Non-alcoholic fatty liver

Liver fibrosis

Severe liver disease

Vaccine Clinical Development

Vaccine research is unique in its ability to have widespread impact on global health. Now more than ever, vaccine development requires a more innovative and efficient approach. Our vaccine service scope covers vaccine clinical design, monitoring, data statistics and biological testing, we work closely with you to develop personalized roadmaps for your vaccine study and aims to maximize efficiency, anticipate challenges, and mitigate risk.

Learn more

Let's Connect for a Conversation